Last filing: Feb 24, 2026. Most recent sale before this period: Sep 22, 2025.
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 0 of the 13 calendar months from Oct 2025 to Oct 2026.
- Last sale before this period: Sep 22, 2025.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Halozyme Therapeutics, Inc. (HALO) | SVP, Chief Financial Officer | Feb 11, 2022 | Feb 24, 2026 |
Recent filings
The last 3 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Feb 23, 2026, Halozyme Therapeutics, Inc.: 6,688 shares vested; 3,608 shares withheld by the company for taxes. 1 filing: 1
- Feb 20, 2026, Halozyme Therapeutics, Inc.: 5,332 shares vested; 2,876 shares withheld by the company for taxes. 1 filing: 1
- Feb 16, 2026, Halozyme Therapeutics, Inc.: 23,773 shares vested; 12,894 shares withheld by the company for taxes. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.